Literature DB >> 376731

Slow reacting substance (SRS) from ionophore A23187-stimulated peritoneal mast cells of the normal rat. II. Evidence for a precursor role of arachidonic acid and further purification.

L D Yecies, S M Johnson, H J Wedner, C W Parker.   

Abstract

The generation of slow reacting substance (SRS) from ionophore A23187-stimulated rat peritoneal mast cells was enhanced by arachidonic acid (AA). This SRS generation was inhibited by 5,8,11,14-eicosatetraynoic acid (ETYA), an acetylenic analogue of AA and an inhibitor of both fatty acid cyclooxygenase and lipoxygenase. Indomethacin, a fatty acid cyclooxgenase inhibitor, had an enhancing effect upon SRS generation. This suggests SRS generation occurred through an ETYA sensitive step--perhaps a lipoxygenase. Radiolabel from [14C]-AA was incorporated into SRS with comigration of radioactivity and bioreactivity in silicic acid and thin layer chromatographies. Upon silicic acid chromatography, the active principle was eluted in the methanol fraction. Two-dimensional thin layer chromatography revealed chromatographic separation from other known spasmogenic substances and phospholipids. Mast cell SRS was found to display physiochemical properties similar to those of rat basophilic leukemia cell SRS, namely: that mast cell SRS generation was 1) enhanced by arachidonic acid; 2) inhibited by ETYA but not by indomethacin; 3) incorporation of [14C]-AA into the active principle; and 4) similar behavior during purification in silicic acid and thin layer chromatographies.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 376731

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  3 in total

1.  The metabolism of arachidonic acid in the isolated tracheal and lung strip preparations of guinea-pigs.

Authors:  H W Mitchell; M A Denborough
Journal:  Lung       Date:  1980       Impact factor: 2.584

2.  Small molecule inhibitors of the Candida albicans budded-to-hyphal transition act through multiple signaling pathways.

Authors:  John Midkiff; Nathan Borochoff-Porte; Dylan White; Douglas I Johnson
Journal:  PLoS One       Date:  2011-09-26       Impact factor: 3.240

3.  Anaphylatoxin C3a enhances mucous glycoprotein release from human airways in vitro.

Authors:  Z Marom; J Shelhamer; M Berger; M Frank; M Kaliner
Journal:  J Exp Med       Date:  1985-04-01       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.